ALDX
Aldeyra Therapeutics, Inc.
0.9159$
-0.8%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.28 | 0.39 | 0.32 | 0.96 | 0.88 | 1.16 | 1.02 | 1.38 | 1.64 | 0.73 | 0.83 | 0.81 | 0.50 | 0.81 | 0.43 | |
| 0.15 | 0.54 | 0.44 | 0.93 | 0.51 | 0.49 | 0.39 | 0.46 | 0.45 | 0.29 | 0.21 | 0.26 | 0.23 | 0.20 | 0.16 | |
| 0.44 | 0.93 | 0.77 | 1.89 | 1.39 | 1.65 | 1.41 | 1.83 | 2.08 | 1.02 | 1.04 | 1.07 | 0.73 | 1.01 | 0.59 | |
| -0.44 | -0.93 | -0.77 | -1.89 | -1.39 | -1.65 | -1.41 | -1.83 | -2.33 | -1.07 | -1.04 | -1.07 | -0.73 | -1.01 | -0.59 | |
| 0.06 | 0.28 | 0.03 | 0.06 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.06 | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | |
| -0.50 | -19.22 | 2.72 | -1.35 | -1.40 | -1.65 | -1.40 | -1.79 | -2.29 | -1.12 | -1.07 | -1.06 | -0.64 | -0.94 | -0.56 | |
| 0.06 | -17.61 | 0.03 | 0.06 | 0.00 | 0.01 | 0.01 | 0.04 | -0.05 | -0.01 | 0.03 | -0.01 | – | -938,919.68 | – | |
| -0.50 | -19.22 | 2.72 | -1.35 | -1.40 | -1.65 | -1.40 | -1.79 | -2.24 | -1.11 | -1.07 | -1.06 | -0.64 | -0.94 | -0.56 | |
| -0.44 | -18.93 | 2.75 | -1.28 | -1.39 | -1.63 | -1.39 | -1.78 | -2.27 | -1.01 | -1.03 | -1.03 | -0.60 | -0.90 | -0.53 |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.